See more. Diagnose better.

We believe A.I. has the power to help Doctors discover and diagnose skin cancer, both easily and effectively.

▶ View Video

Contact Us

We work closely with physicians in North America, Australia & New Zealand to ensure our products are not only safe and effective, but fit-for-purpose and easy to use.

Customer-centric approach

Combining one of the largest known databases of skin lesions and next-generation technology, we're desiging products with patient safety at the heart of what we do.

Next-generation A.I. technology

Our clinical program and medical advisory board have a robust clinical roadmap to ensure our technologies are proven as safe and effective.

Evidence-backed medicine

Kāhu A.I. technology is being developed in collaboration with Molemap Ltd, to help Doctors discover and diagnose skin cancer.

Support healthcare professionals

What we do

Absolutely - and one we think is worth solving.

Brigitte de Lambert, Investment Manager

Is Skin Cancer & Melanoma a problem?

Kāhu Team

Adults in the U.S., during 2007–2011 were treated for skin cancer each year. (7)

5M

Average annual total treatment costs during 2007-2011. (8)

8.1B

Estimated annual costs associated with lost workdays and restricted-activity days for NMSC and melanoma. (9)

106.2M

New normal, same cancer

Whilst COVID-19 has impacted healthcare systems around the world, skin cancer remains ever present. The leading Australasian specialists at the frontline of the battle, MoleMap, figured they could do better. (1)

Learn more

Learn more about the
challenges for the health system

See our Research

We can confidently say that Kāhu will have seen more skin lesions and melanomas than most healthcare professionals.

How Kāhu AI works

Unlike other technologies in this space, Kāhu technology is being developed by leveraging MoleMap’s world-leading database of high-quality dermatological images. (22)

identified categories

1K+

classified images

1M+

patients

500K+

Our purpose

Kāhu A.I. is a clinical decision support tool and is not intended to replace the clinical decisions made by healthcare professionals.
It is intended to give the clinicians more information about skin lesions to help them make more informed decisions. Just like a blood test or an X-ray might.

Now that’s something with the potential to give everyone peace of mind.